Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: Jim Mac who wrote (113)	11/6/1997 1:05:00 AM
From: Koolaide	Read Replies (2) \| Respond to of 413

If the industry comes under pricing pressure, which is impossible to predict, since at this time managed care does not cover the proceedure, (and I know of very few elective surguries that are price elastic)the entity that can provide the access at the lowest price will ultimately survive and thrive. As far as small excimers (such as the newest version of the star by VISX and/or the Autononmous, or the Nidek or the Technolas or the whatever,,,,,the very fact that these potential upgrades in technology may come to market someday emphasizes the risk that a doctor must take when purchasing one rather than participating in a shared access enviroment. My beleif is that after VISX's current trade in progaram ends in December, they will sell very few machines going forward. I do beleive that case volumes industry wide will continue to grw sharply and that LVCI will get more than their share of that growth. Holmiums and hyperopia? That is a very small percentage of the population and the long term stability of the "hot holmium" is still questionable. One you didn't mention is the corneal ring (long surgical time to install, and therefor not too profitable for the average refractive surgeon.) As far as the price of the stock, I choose to beleive that the price will approximate the current, dicounted value of future earnings. So when the earings model becomes more predictable in terms of growth in proceedures, gross margin expirience and accepted business model the price will move higher. I personally look for that to begin to happen when the company reports the October quarter, sometime in early december. You were lucky and smart to catch the stock on the Tuesday morning meltdown. Most people either didn't know it got that low or were too frightened by the "Hong Kong" rumblings to stand up and buy the dips...... In any case, good luck to you..........